Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sung Hwa Seo has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single matter is handled by examiner ROBINSON, HOPE A. With only 1 pending office action, the current prosecution resources are dedicated to this individual case. This allows for a highly specialized response to the examiner's technical findings. The singular focus ensures that the legal strategy is perfectly aligned with the examiner's feedback.
The case resides within 1 distinct art unit. ROBINSON, HOPE A is the busiest examiner with 1 pending office action. Having 1 distinct examiner and 1 distinct art unit means the current pharmaceutical patent is subject to a single point of evaluation. This centralized structure allows for a very focused approach to resolving the pending matter. The outcome of this single office action is the sole focus of the current biotechnology prosecution strategy. By dedicating effort to 1 pending office action, the applicant can ensure a robust technical justification for the claims.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, HOPE A | 1 | 67.7% | +43.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18865992 | METHOD FOR PRODUCING FROM FATTY ALCOHOLS MONOMERS FOR PRODUCING VARIOUS SYNTHETIC RESINS | ROBINSON, HOPE A | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18865992 | METHOD FOR PRODUCING FROM FATTY ALCOHOLS MONOMERS FOR PRODUCING VARIOUS SYNTHETIC RESINS | ROBINSON, HOPE A | 1652 | §112 | Non-Final OA | — | Pending | Nov 14, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSung Hwa Seo has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Hope A Robinson has the most, with 1 of Sung Hwa Seo's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
